Susceptibility of Streptococcus agalactiae to erythromycin and clindamycin in pregnant women in the prenatal screening
Clin. biomed. res
;
38(4): 311-315, 2018.
Article
Dans Anglais
| LILACS
| ID: biblio-1023693
ABSTRACT
Introduction:
Group B streptococcus (GBS), or Streptococcus agalactiae, is a bacterium found in normal human microbiota. However, it may cause neonatal pneumonia, sepsis, and meningitis. Genital colonization in pregnant women is associated with a higher risk of preterm birth. The treatment of choice is antibiotic therapy with beta-lactams, but in the case of multidrug-resistance, erythromycin and clindamycin can be used.Methods:
This study evaluated bacterial cultures in the period from 2014 to 2015 from a group of 29,875 pregnant women. GBS colonization and resistance to erythromycin and clindamycin were investigated.Results:
Positive cultures were found in 26.8% and 26.1% of the samples in 2014 and 2015, respectively. Levels of resistance to erythromycin and clindamycin were, respectively, 2.4% and 5.5% in 2014 and 3.2% and 6.5% in 2015.Conclusion:
The investigation of GBS colonization and the evaluation of GBS resistance to erythromycin and clindamycin are of extreme relevance, given the increasing incidence of bacterial resistance, risks of preterm birth. (AU)
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Infections à streptocoques
/
Streptococcus agalactiae
/
Résistance microbienne aux médicaments
Type d'étude:
Etude diagnostique
/
Étude de dépistage
Limites du sujet:
Femelle
/
Humains
/
Grossesse
langue:
Anglais
Texte intégral:
Clin. biomed. res
Thème du journal:
Médicament
Année:
2018
Type:
Article
Pays d'affiliation:
Brésil
Institution/Pays d'affiliation:
Instituto Hermes Pardini/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS